Overexpression of p68 mRNA in head and neck squamous cell carcinoma cells

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 1941-1946

  Beier, Ulf Henning ^a   Maune, Steffen ^b   Meyer, Jens E ^c   Görögh, Tibor ^b,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

Differential display; mRNA expression; p68; Squamous cell carcinoma

Indexed keywords

MESSENGER RNA; PROTEIN P68;

ARTICLE; CANCER GROWTH; CARCINOMA CELL; CONTROLLED STUDY; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE ISOLATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CLONING, MOLECULAR; EIF-2 KINASE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TRANSFORMATION, GENETIC;

EID: 33745587030     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Werner J: The current status of the care for lymph drainage in malignant head-neck tumors. Laryngorhinootologie 76: 643-644, 1997.
2. Moisa I, Mahadevia P and Silver CE: Unusual tumors of the larynx. In: Laryngeal Cancer. Silver C (ed.). New York, NY: Thieme, pp. 33-43, 1991.
3. Argiris A: Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14(3): 323-329, 2002.
4. Koch W and Sidransky D: Molecular markers of radiation effectiveness in head and neck squamous cell carcinoma. Semin Radiat Oncol 14(2): 130-138, 2004.
5. Akervall J: Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev 24(1): 87-94, 2005.
6. Hardisson D: Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260(9): 502-508, 2003.
7. Brennan J, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA and Sidransky D: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332(11): 712-717, 1995.
8. Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL and Hung MC: Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin Cancer Res 3(1): 3-9, 1997.
9. Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, Sanghavi V and Mehta AR: High frequency mutations in codons 12 and 61 of Ha-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 63: 573-578, 1991.
10. Dolcetti R., Doglioni C, Maestro R, Gasparotto D, Barzan L, Pastore A, Romanelli M and Boiocchi M: P53 over-expression in an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 52: 178-182, 1992.
11. Fan C, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ and Huang DP: Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol 31(2): 169-178, 2000.
12. Gorogh T, Beier UH, Baumken J, Meyer JE, Hoffmann M, Gottschlich S and Maune S: Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. Head Neck [Epub ahead of print], 2005.
13. Bauer D, Muller H, Reich J, Riedel H, Ahrenkiel V, Warthoe P and Strauss M: Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res 21(18): 4272-4280, 1993.
14. Liang P and Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257(5072): 967-971, 1992.
15. Ford M, Anton IA and Lane DP: Nuclear protein with sequence homology to translation initiation factor eIF-4A. Nature 332(6166): 736-738, 1988.
16. Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, Schnier J and Slonimski PP: Birth of the D-E-A-D box. Nature 337(6203): 121-122, 1989.
17. Iggo R, Jamieson DJ, MacNeill SA, Southgate J, McPheat J and Lane DP: P68 RNA helicase: identification of a nucleolar form and cloning of related genes containing a conserved intron in yeasts. Mol Cell Biol 11(3): 1326-1333, 1991.
18. Haines G, Panos RJ, Bak PM, Brown T, Zielinski M, Leyland J and Radosevich JA: Interferon-responsive protein kinase (p68) and proliferating cell nuclear antigen are inversely distributed in head and neck squamous cell carcinoma. Tumor Biol 19(1): 52-59, 1998.
19. Hahn W and Weinberg RA: Modelling the molecular circuitry of cancer. Nat Rev Cancer 2(5): 331-341, 2002.
20. Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B and Kalthoff H: Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 58(8): 1741-1749, 1998.
21. Stevenson R, Hamilton SJ, MacCallum DE, Hall PA and Fuller-Pace FV: Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J Pathol 184(4): 351-359, 1998.
22. Causevic M, Hislop RG, Kernohan NM, Carey FA, Kay RA, Steele RJ and Fuller-Pace FV: Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene 20(53): 7734-7743, 2001.
23. Wei Y and Hu MH: The study of p68 RNA helicase on cell transformation. Yi Chuan Xue Bao 28(11): 991-996, 2001.
24. Kahlina K, Goren I, Pfeilschifter J and Frank S: P68 DEAD box RNA helicase expression in keratinocytes. Regulation, nucleolar localization, and functional connection to proliferation and vascular endothelial growth factor gene expression. J Biol Chem 279(43): 44872-44882, 2004.
25. Zhou Y, Gobi A, Wang S, Jacobsen MB, Janson ET, Haines GK III, Radosevich JA and Oberg K: Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours. Eur J Cancer 34(13): 2046-2052, 1998.
26. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR and Hovanessian AG: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62(2): 379-390, 1990.
27. Feng Q, Cao R, Xia L, Erdjument-Bromage H, Tempst P and Zhang Y: Identification and functional characterization of the p66/p68 components of the MeCP1 complex. J Dermatol Sci 22(2): 536-546, 2002.
28. Wilson B, Bates GJ, Nicol SM, Gregory DJ, Perkins ND and Fuller-Pace FV: The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol 5(6): 11, 2004.
29. Buelt M, Glidden BJ and Storm DR: Regulation of p68 RNA helicase by calmodulin and protein kinase C. J Biol Chem 296(47): 29367-29370, 1994.
30. Yuspa S: The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 17(1): 1-7, 1998.
31. Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D and Demers L: Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and -beta overexpression. Cell Growth Differ 7(9): 1187-1198, 1996.
32. Jacobs E, Bulpitt PC, Coutts IG and Robertson JF: New calmodulin antagonists inhibit in vitro growth of human breast cancer cell lines independent of their estrogen receptor status. Anticancer Drugs 11(2): 63-68, 2000.
33. Yang L, Lin C and Liu ZR: Signaling to the DEAD box - regulation of DEAD-box p68 RNA helicase by protein phosphorylations. Cell Signal 17(12): 1495-1504, 2005.